Clinical Trial Update: Tolerability of Acthar for the Treatment of Multiple Sclerosis in Relapses (TAMS) [NA]

View source ↗

Summary

Clinical trial update on tolerability of Acthar for treating relapses in Relapsing Remitting Multiple Sclerosis; study completed with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• Acthar (repository corticotropin injection)

Snippet

Sponsor: OhioHealth | Conditions: Relapsing Remitting Multiple Sclerosis | NA | Status: COMPLETED | Results posted: 2020-09-01